Search results
In 'The Unexpected,' Emily Oster tackles the emotional toll of difficult pregnancies
NPR· 3 days agoThe Unexpected: Navigating Pregnancy During and After Complications, which came out this week,...
Perimenopause may raise risk of one mental health condition by 40%, study finds
KTBS Shreveport· 5 days agoNow, a new study has quantified the risk of depression during the transition, known as perimenopause — showing that women in this stage are about 40% more likely to experience ...
FOX13 Resource Guide: Mental health help for new mothers
FOX 13 Memphis· 3 days ago"It's really a public health crisis but a kind of silent one," said Wendy Davis with Postpartum...
Kenneth Cole Partners With Illustrator Sophia Chang to Raise Awareness on Maternal Mental Health
WWD via Yahoo News· 5 days agoI had a very difficult postpartum journey, and I wish there was more education for women around...
Mizuho Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $18.00
ETF DAILY NEWS· 7 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its price target lowered by Mizuho from $20.00 to $18.00 in a report published on Friday, Benzinga reports. The brokerage currently has a neutral ...
World Maternal Mental Health Day spotlights 'silent' public health crisis
WPBF Palm Beach· 4 days agoDavis, who works with the non-profit organization, emphasized that maternal mental health issues can often be surprising and embarrassing for those experiencing them. Symptoms of postpartum ...
Reunion Neuroscience Inc. Announces $103 Million Series A Financing Co-Led by MPM BioImpact and Novo...
Benzinga· 3 days agoReunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the close of a $103 million Series A financing co-led ...
Tuesday briefing: Columbia University student protest; Charlotte shooting; Trump trial;...
Washington Post· 5 days agoCatch up in minutes with these 7 stories.
Q2 2024 EPS Estimates for Sage Therapeutics, Inc. Cut by William Blair (NASDAQ:SAGE)
ETF DAILY NEWS· 6 days agoSage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Research analysts at William Blair decreased their Q2 2024 EPS estimates for shares of Sage Therapeutics in a research note issued on Thursday ...
HC Wainwright Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $25.00
ETF DAILY NEWS· 7 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by HC Wainwright from $28.00 to $25.00 in a research report sent to investors on Friday morning, Benzinga reports. They ...